177 related articles for article (PubMed ID: 21597314)
1. Deletion of thyrotropin receptor residue Asp403 in a hyperfunctioning thyroid nodule provides insight into the role of the ectodomain in ligand-induced receptor activation.
Nishihara E; Chen CR; Mizutori-Sasai Y; Ito M; Kubota S; Amino N; Miyauchi A; Rapoport B
J Endocrinol Invest; 2012 Jan; 35(1):49-53. PubMed ID: 21597314
[TBL] [Abstract][Full Text] [Related]
2. Hyperfunctioning thyroid nodules in toxic multinodular goiter share activating thyrotropin receptor mutations with solitary toxic adenoma.
Tonacchera M; Chiovato L; Pinchera A; Agretti P; Fiore E; Cetani F; Rocchi R; Viacava P; Miccoli P; Vitti P
J Clin Endocrinol Metab; 1998 Feb; 83(2):492-8. PubMed ID: 9467563
[TBL] [Abstract][Full Text] [Related]
3. Identification and functional characterization of two novel activating thyrotropin receptor mutants in toxic thyroid follicular adenomas.
Castro I; Lima L; Seoane R; Lado-Abeal J
Thyroid; 2009 Jun; 19(6):645-9. PubMed ID: 19499991
[TBL] [Abstract][Full Text] [Related]
4. Two rare TSH receptor amino acid substitutions in toxic thyroid adenomas.
Nanba K; Usui T; Minamiguchi S; Mori Y; Watanabe Y; Honda K; Asato R; Nakao K; Kawashima ST; Yuno A; Tamanaha T; Tagami T; Naruse M; Akiyama Y; Shimatsu A
Endocr J; 2012; 59(1):13-9. PubMed ID: 22001338
[TBL] [Abstract][Full Text] [Related]
5. A tyrosine residue on the TSH receptor stabilizes multimer formation.
Latif R; Michalek K; Morshed SA; Davies TF
PLoS One; 2010 Feb; 5(2):e9449. PubMed ID: 20195479
[TBL] [Abstract][Full Text] [Related]
6. Functioning and nonfunctioning thyroid adenomas involve different molecular pathogenetic mechanisms.
Tonacchera M; Vitti P; Agretti P; Ceccarini G; Perri A; Cavaliere R; Mazzi B; Naccarato AG; Viacava P; Miccoli P; Pinchera A; Chiovato L
J Clin Endocrinol Metab; 1999 Nov; 84(11):4155-8. PubMed ID: 10566665
[TBL] [Abstract][Full Text] [Related]
7. Genetic alterations in thyroid hyperfunctioning adenomas.
Russo D; Arturi F; Wicker R; Chazenbalk GD; Schlumberger M; DuVillard JA; Caillou B; Monier R; Rapoport B; Filetti S
J Clin Endocrinol Metab; 1995 Apr; 80(4):1347-51. PubMed ID: 7714109
[TBL] [Abstract][Full Text] [Related]
8. Rarity of oncogenic mutations in the thyrotropin receptor of autonomously functioning thyroid nodules in Japan.
Takeshita A; Nagayama Y; Yokoyama N; Ishikawa N; Ito K; Yamashita T; Obara T; Murakami Y; Kuma K; Takamatsu J
J Clin Endocrinol Metab; 1995 Sep; 80(9):2607-11. PubMed ID: 7673402
[TBL] [Abstract][Full Text] [Related]
9. Mutations of thyrotropin receptor isolated from thyroid autonomous functioning adenomas confer TSH-independent growth to thyroid cells.
Porcellini A; Ruggiano G; Pannain S; Ciullo I; Amabile G; Fenzi G; Avvedimento EV
Oncogene; 1997 Aug; 15(7):781-9. PubMed ID: 9266964
[TBL] [Abstract][Full Text] [Related]
10. Activating TSH-receptor mutation (Met453Thr) as a cause of adenomatous non-autoimmune hyperthyroidism in a 3-year-old boy.
Kraemer S; Rothe K; Pfaeffle R; Fuehrer-Sakel D; Till H; Muensterer OJ
J Pediatr Endocrinol Metab; 2009 Mar; 22(3):269-74. PubMed ID: 19492584
[TBL] [Abstract][Full Text] [Related]
11. Two novel mutations in the sixth transmembrane segment of the thyrotropin receptor gene causing hyperfunctioning thyroid nodules.
Gozu H; Avsar M; Bircan R; Claus M; Sahin S; Sezgin O; Deyneli O; Paschke R; Cirakoglu B; Akalin S
Thyroid; 2005 Apr; 15(4):389-97. PubMed ID: 15876166
[TBL] [Abstract][Full Text] [Related]
12. Identification and functional characterization of two new somatic mutations causing constitutive activation of the thyrotropin receptor in hyperfunctioning autonomous adenomas of the thyroid.
Paschke R; Tonacchera M; Van Sande J; Parma J; Vassart G
J Clin Endocrinol Metab; 1994 Dec; 79(6):1785-9. PubMed ID: 7989485
[TBL] [Abstract][Full Text] [Related]
13. [Point mutation of thyrotropin receptors as the main cause of autonomously functioning thyroid nodules: experiences in the framework of our Styrian patients].
Lax SF; Semlitsch G; Noiges R; Höfler G
Acta Med Austriaca; 2000; 27(2):49-50. PubMed ID: 10812465
[TBL] [Abstract][Full Text] [Related]
14. Primary culture of cells from hyperfunctioning thyroid adenoma with an activating mutation of G alphas.
Kamiya Y; Murakami M; Yanagita Y; Koitabashi H; Nagamachi Y; Hosoi Y; Ogiwara T; Mizuma H; Iriuchijima T; Mori M
Mol Cell Endocrinol; 1998 Mar; 138(1-2):137-42. PubMed ID: 9685222
[TBL] [Abstract][Full Text] [Related]
15. A novel activating mutation in the thyrotropin receptor gene in an autonomously functioning thyroid nodule developed by a Japanese patient.
Kosugi S; Hai N; Okamoto H; Sugawa H; Mori T
Eur J Endocrinol; 2000 Oct; 143(4):471-7. PubMed ID: 11022192
[TBL] [Abstract][Full Text] [Related]
16. Lack of in vitro constitutive activity for four previously reported TSH receptor mutations identified in patients with nonautoimmune hyperthyroidism and hot thyroid carcinomas.
Jaeschke H; Mueller S; Eszlinger M; Paschke R
Clin Endocrinol (Oxf); 2010 Dec; 73(6):815-20. PubMed ID: 20846293
[TBL] [Abstract][Full Text] [Related]
17. A human monoclonal autoantibody to the thyrotropin receptor with thyroid-stimulating blocking activity.
Sanders J; Evans M; Betterle C; Sanders P; Bhardwaja A; Young S; Roberts E; Wilmot J; Richards T; Kiddie A; Small K; Platt H; Summerhayes S; Harris R; Reeve M; Coco G; Zanchetta R; Chen S; Furmaniak J; Smith BR
Thyroid; 2008 Jul; 18(7):735-46. PubMed ID: 18631002
[TBL] [Abstract][Full Text] [Related]
18. Somatic mutations in the thyrotropin receptor gene and not in the Gs alpha protein gene in 31 toxic thyroid nodules.
Führer D; Holzapfel HP; Wonerow P; Scherbaum WA; Paschke R
J Clin Endocrinol Metab; 1997 Nov; 82(11):3885-91. PubMed ID: 9360556
[TBL] [Abstract][Full Text] [Related]
19. Functional significance of the thyrotropin receptor germline polymorphism D727E.
Sykiotis GP; Neumann S; Georgopoulos NA; Sgourou A; Papachatzopoulou A; Markou KB; Kyriazopoulou V; Paschke R; Vagenakis AG; Papavassiliou AG
Biochem Biophys Res Commun; 2003 Feb; 301(4):1051-6. PubMed ID: 12589819
[TBL] [Abstract][Full Text] [Related]
20. Hyperfunctioning thyroid adenoma and activating mutations in the TSH receptor gene.
Polak M
Arch Med Res; 1999; 30(6):510-3. PubMed ID: 10714365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
